All Cancers

IRB #H-39964/ Leuko Labs #PC001 (Leuko): Study to Evaluate the Usability of PointCheck, a Novel Optical Technology for Screening Non-Invasively Severe Neutropenia

IRB #H-38024/ BMC #Biobank: Prospective Collection of Microbiome and Associated Biologic Samples in Patients with Malignancies and Hematologic Diseases

Metastatic/Advanced 2nd+ Line Solid Tumors:

KRAS/NRAS/HRAS/BRAF positive
CIRB #H-42956/ ETCTN #10449: A Phase 1 Study of ZEN003694 in Combination with Binimetinib in Solid Tumors with RAS Pathway Alterations and Triple Negative Breast Cancer (pending IRB approval)